FDA Plans To Rely On Non-U.S. Regulators In Global Drug Quality Initiative
This article was originally published in The Tan Sheet
Executive Summary
FDA restructures its staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality, but it offers few details on upcoming plans.
You may also be interested in...
FDA Posts Investigator In Singapore, But Trims Foreign Office List
FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA is shifting from a predominantly domestic focus to global as drug criminal organizations spread worldwide,
FDA Posts Investigator In Singapore, But Trims Foreign Office List
FDA's Office of International Programs consolidates its China offices to "strategically focus its resources." FDA shifts away from primarily a domestic focus to global as drug criminal organizations spread globally
How FDA Plans To Stop Worrying And Love Globalization
New deputy commissioner Howard Sklamberg tells “The Pink Sheet” that globalization of the drug supply eventually will become more commonplace, and ideally less of a concern, for American consumers.